Page last updated: 2024-12-07
primisulfuron
Description
Primisulfuron is a sulfonylurea herbicide that inhibits acetolactate synthase (ALS), an enzyme essential for the biosynthesis of branched-chain amino acids in plants. Its synthesis involves multiple steps, starting from 2-chloro-4-trifluoromethylpyrimidine. Primisulfuron is highly effective in controlling broadleaf weeds in various crops, including cereals, soybeans, and cotton. It is widely studied due to its selectivity, persistence in soil, and potential environmental impact. Studies on primisulfuron focus on its mode of action, efficacy, and potential for resistance development in weeds. It is also studied for its potential effects on non-target organisms and its fate in the environment.'
primisulfuron: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 91774 |
CHEMBL ID | 2251449 |
CHEBI ID | 82031 |
SCHEMBL ID | 54482 |
MeSH ID | M0368608 |
Synonyms (20)
Synonym |
primisulfuron |
2-[[4,6-bis(difluoromethoxy)pyrimidin-2-yl]carbamoylsulfamoyl]benzoic acid |
113036-87-6 |
C18883 |
primisulfuron [iso] |
7ufu80lx99 , |
benzoic acid, 2-(((((4,6-bis(difluoromethoxy)-2-pyrimidinyl)amino)carbonyl)amino)sulfonyl)- |
unii-7ufu80lx99 |
AKOS015900311 |
SCHEMBL54482 |
chebi:82031 , |
CHEMBL2251449 |
2-(((((4,6-bis(difluoromethoxy)-2-pyrimidinyl)amino)carbonyl)amino)sulfonyl)benzoic acid |
2-(4,6-bis(difluoromethoxy)pyrimidin-2-ylcarbamoylsulfamoyl)benzoic acid |
DTXSID40150270 |
benzoic acid, 2-[[[[[4,6-bis(difluoromethoxy)-2-pyrimidinyl]amino]carbonyl]amino]sulfonyl]- |
2-(n-(4,6-bis(difluoromethoxy)pyrimidin-2-ylcarbamoyl)sulfamoyl)benzoic acid |
FT-0725480 |
Q27155699 |
benzoic acid,2-[[[[[4,6-bis(difluoromethoxy)-2-pyrimidinyl]amino]carbonyl]amino]sulfonyl]- |
Research Excerpts
Dosage Studied
Drug Classes (1)
Class | Description |
benzoic acids | Any aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.23
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 22.23 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.83 (4.65) | Search Engine Demand Index | 24.97 (26.88) | Search Engine Supply Index | 4.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |